Down 79%, Is Moderna Stock a Bad-News Buy on the Dip?
Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but ...
Is Moderna (MRNA) the Stock That Will Go to the Moon According to Reddit?
We recently published a list of 11 Stocks That Will Go to the Moon According to Reddit. In this article, we are going to take ...
Moderna target nearly halved by Morgan Stanley on weak guidance
The firm noted Moderna's reduced 2024 sales forecast of $3.0–$3.1 billion, down from $3.0–$3.5 billion, driven by declines in ...
Moderna's Road To Stopping The Red
Moderna is down 80% from its 52-week high as revenues continue to fall and the new RSV vaccine has performed poorly. Read my ...
Moderna’s Financial Outlook: Hold Rating Amidst Competitive Challenges and Strategic Adjustments
In a report released today, Terence Flynn from Morgan Stanley assigned a Hold rating on Moderna (MRNA – Research Report), with a price target ...
Moderna price target lowered to $38 from $70 at Morgan Stanley
Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Moderna (MRNA) to $38 from $70 and keeps an Equal Weight rating on the ...
Moderna remains the most shorted stock among S&P 500 healthcare stocks in the last month of 2024
Short interest for healthcare stocks in S&P 500 rose slightly in December vs. November, while Moderna continued to be the most shorted stock of the month. The average short interest for S&P 500 Health ...